Scaling-Up Stepped Care for Women's Mental Health in Primary Care in an LMIC
NCT ID: NCT04110405
Last Updated: 2023-06-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
630 participants
INTERVENTIONAL
2020-08-14
2024-10-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Stepped Telemental Health Care Intervention for Depression
NCT01906476
Caregiver Stress and Sleep Study
NCT05219955
Nurse-led Case Management for Diabetes and Cardiovascular Disease Patients With Depression
NCT00468676
A Transdiagnostic Course for Common Mental Health Problems in Primary Care
NCT04522713
Evaluation of a Collaborative Behavioral Health Program Implementation in Primary Care
NCT04321876
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Globally, young women bear a disproportionate burden of common mental disorders, and especially including depression and potentially co-occurring anxiety. With current care models, this burden cannot be lifted without finding ways to deliver mental health prevention and treatment services and illness self-management to women in primary care. Our previous research in Tajikistan has demonstrated that women are exposed to serious risks for mental illness, and how peers and primary care nurses have played major but largely informal roles in helping women with mental health problems. Therefore, the investigators developed and tested for feasibility a stepped care model which showed very strong treatment effects. This stepped care model involves three steps. Step 1 is a peer and nurse co-led 8-session group based upon BRIDGES. Step 2 is peer or nurse led 6-session individual meetings based upon Interpersonal Psychotherapy. Step 3 is primary care physician led medication treatment with Amitriptyline.
This project will scale-up the intervention in multiple polyclinics, so as to examine its effectiveness (Aim 2) and to compare two implementation strategies (Aim 3). This presents a remarkable opportunity to advance both services and science of mental health in Tajikistan.
Aim 1. To assess the effectiveness of the stepped care model with 420 women who have depression and potential co-occurring anxiety, recruited from 12 primary care clinics in Tajikistan, compared with standard of care plus provision of healthy lifestyle materials, with another 210 women recruited from 6 primary care clinics, including assessing mediators and moderators (e.g. executive control efficiency, trauma exposure).
Aim 2. To assess whether a clinic implementation team moderates women's reduction in depression post-intervention, as well as clinic-level (leadership support and degree of implementation) and provider-level (motivation and fidelity) moderators.
Aim 3. To establish a national mental health research network that focuses on improving the standard of mental health care and access to services by building mental health implementation research capacity.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Stepped Care
To assess the effectiveness of the stepped care model with 420 women who have depression and potential co-occurring anxiety, recruited from 12 primary care clinics in Tajikistan.
Stepped Care
This stepped care model involves three steps. Step 1 is a peer and nurse co-led 8-session group based upon BRIDGES. Step 2 is peer or nurse led 6-session individual meetings based upon Interpersonal Psychotherapy. Step 3 is primary care physician led medication treatment with Amitriptyline.
Standard of Care plus Healthy Lifestyle
To compare standard of care plus healthy lifestyle materials with 210 women recruited from 6 primary care clinics in Tajikistan.
Standard of Care plus Healthy Lifestyle
Standard outpatient care supplemented with literature on healthy lifestyles will serve as an enhanced control condition. In each clinic, non-specialty mental health care is available in the form of counseling from doctors or nurses along with psychiatric medication management. Given the difficulties faced by women in Tajikistan, ethical responsibility compels us to enhance the control condition by having nurses distribute written materials on healthy eating, physical fitness, and personal hygiene, at a reading level which will be widely accessible.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Stepped Care
This stepped care model involves three steps. Step 1 is a peer and nurse co-led 8-session group based upon BRIDGES. Step 2 is peer or nurse led 6-session individual meetings based upon Interpersonal Psychotherapy. Step 3 is primary care physician led medication treatment with Amitriptyline.
Standard of Care plus Healthy Lifestyle
Standard outpatient care supplemented with literature on healthy lifestyles will serve as an enhanced control condition. In each clinic, non-specialty mental health care is available in the form of counseling from doctors or nurses along with psychiatric medication management. Given the difficulties faced by women in Tajikistan, ethical responsibility compels us to enhance the control condition by having nurses distribute written materials on healthy eating, physical fitness, and personal hygiene, at a reading level which will be widely accessible.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* score \>16 on the HAM-D
* no current or past substance use
* willing to participate in the intervention and research procedures
* able to give written informed consent.
Exclusion Criteria
* women who do not score \>16 on the HAM-D
18 Years
45 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Prisma Research Center
UNKNOWN
University of Utah
OTHER
New York University
OTHER
University of Illinois at Chicago
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Stevan Weine
Professor of Psychiatry
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
City Health Center #4
Dushanbe, , Tajikistan
City Health Center #5
Dushanbe, , Tajikistan
Dushanbe City Health Center #12
Dushanbe, , Tajikistan
Dushanbe City Health Center #13
Dushanbe, , Tajikistan
Dushanbe City Health Center #15
Dushanbe, , Tajikistan
Dushanbe City Health Center #1
Dushanbe, , Tajikistan
Dushanbe City Health Center #2
Dushanbe, , Tajikistan
Dushanbe City Health Center #6
Dushanbe, , Tajikistan
Guliston District Health Center
Guliston, , Tajikistan
Gafurov District Health Center
Khujand, , Tajikistan
Kayrokum District Health Center #7
Khujand, , Tajikistan
Khujand City Health Center #1
Khujand, , Tajikistan
Khujand City Health Center #2
Khujand, , Tajikistan
Khujand City Health Center #3
Khujand, , Tajikistan
Khujand City Health Center #4
Khujand, , Tajikistan
Khujand City Health Center #5
Khujand, , Tajikistan
Khujand City Health Center #6
Khujand, , Tajikistan
Rudaki District Health Center
Rŭdakí, , Tajikistan
Shahrinav District Health Center
Shahrinav, , Tajikistan
Varzob District Health Center
Varzob, , Tajikistan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2019-0745
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.